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DNA microarray hybridization was used to measure the changes of mRNA levels over time during the development
of delayed pigmented spots on the dorsal skin of F1 mice of HR-1  HR/De. Upregulation of a number of interferon
(IFN)-c-stimulated genes was detected in delayed pigmented lesions, suggesting that IFN-c may play a pivotal role
in the development of delayed pigmented spots in this model. Upregulation of these genes was further supported
by the increased protein expression level of IFN-c in the lesions. Epidermal inﬁltration of CD8þ T lymphocytes and
mast cell accumulation in the dermis were observed in delayed pigmented spots. Genes encoding chemokines
such as monocyte chemoattractant protein-2 (MCP-2), IFN-inducible protein 10 (IP-10), and monokineinduced by
IFN-c (MIG) were among those upregulated by IFN-c. We hypothesize that chemokines produced in the epidermis
induce migration of inﬂammatory cells, such as T lymphocytes, mast cells, and macrophages, to the vicinity of
melanocytes. Keratinocytes, T lymphocytes, mast cells, and macrophages would become involved in an interactive
network, providing a suitable local environment for melanocyte activation. In this environment, melanocytes are
exposed to an extensive array of secreted mediators. Reciprocal activation among these cells to maintain this
interactive network results in constitutive melanocyte activation and chronic melanin synthesis in delayed pig-
mented lesions.
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Aging causes noticeable, and usually unwanted, changes in
the appearance of human skin. Skin aging results from the
synergistic effects of intrinsic (chronological) aging and ex-
trinsic photoaging. Development of pigmented spots is one
of the representative symptoms of photoaging. Among
many kinds of pigmented spots formed in human skin,
freckles, melasma, and solar lentigines are most commonly
observed. Although freckles are seen only in sun-exposed
areas and ultraviolet (UV) exposure makes them worse,
freckles have a genetic basis and belong to congenital
hyperpigmentations (Zhang et al, 2004). Melasma and solar
lentigines belong to acquired hyperpigmentations. Although
melasma is also worsened by UV exposure, it is observed in
women taking oral contraceptives or during pregnancy.
Therefore, melasma is far more common in women. In con-
trast, solar lentigines are observed almost equally in men
and women. Solar lentigines are dark brown spots that oc-
cur on sun-exposed areas of skin, typically on the face,
backs of the hands, upper back, and shoulders. Solar lent-
igines are common in middle-aged or older persons, and
are considered to be a hallmark of aged skin. It is thought
that cumulative UV exposure causes these spots (Bastiaens
et al, 2004). Therefore, solar lentigines can be considered as
representative pigmented spots in photoaging.
As far as investigations of solar lentigines are concerned,
almost all have been histopathological studies, and little
work has been carried out at the molecular level (Andersen
et al, 1997). Although considerable knowledge about acute
pigmentation has recently been accumulated, little is yet
known about the mechanism of chronic- and delayed-type
hyperpigmentations such as solar lentigines. Elucidation of
the underlying mechanism of pigmented spot formation has
been hampered by the difficulties in examining the forma-
tion process in humans, as well as the lack of an appro-
priate animal model.
HR-1 mice are widely used to investigate skin properties.
Wrinkles and sagging have been elicited and studied on
HR-1 skin (Bissett et al, 1989). Melanocytes in albino HR-1
mice, however, do not appear to be affected by UV expo-
sure even though the hair follicle defects result in these cells
remaining in an epidermis location in adult skin. Although
studies of acute pigmentation induced by UV exposure of
pigmented hairy or hairless mice have been reported (Sato
and Kawada, 1972; Uesugi, 1978), there has been no report
describing the experimental induction of delayed pigmented
spots such as solar lentigines. It is thought that delayed
pigmentation is distinct from the acute pigmentation uni-
formly induced on the irradiated area during UV expo-
sure. F1 mice of HR-1 (aabbccDDPPhrhr)  HR/De
Abbreviations: IFN, interferon; IP-10, inducible protein 10; ISG15,
IFN-stimulated protein 15 kDa; MCP-2, monocyte chemoattractant
protein-2; MIG, monokineinduced by IFN-g; SCF, stem cell factor;
UV, ultraviolet
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(AABBCCDDpphrhr) are homozygous or heterozygous
dominant for the main coat color genes (AaBbCcDDPphrhr)
and represent a unique model in which delayed pigmented
spots are induced long after UV irradiation (Naganuma et al,
2001).
DNA microarrays provide a powerful tool to analyze gen-
ome-wide transcriptional regulation systematically. We
adapted this tool to examine the dynamics of delayed pig-
mented spot formation in F1 mice of HR-1  HR/De by
simultaneously examining the expression of tens of thou-
sands of genes at successive time points during the course
of development of the pigmentation.
Results
Observation of development of delayed pigmented
spots The results are shown in Fig 1. F1 hairless mice of
HR-1  HR/De showed no tanning at the start of UV irra-
diation. An apparently uniform acute pigmentation was ob-
served 2 wk after the first UV irradiation (Fig 1a). Acute
pigmentation persisted during irradiation. While irradiation
was continuing, the peak of pigmentation was seen at the
fourth week and exposure for over 4 wk did not produce
darker pigmentation. After cessation of UV irradiation, this
pigmentation gradually disappeared and after about 2 wk
the skin color became the same as that of non-irradiated
control skin (Fig 1b). When observation was continued after
the recovery of normal skin color, the skin showed no pig-
mentation for around 10 wk. At about 25 wk, small pig-
mented spots began to develop on the dorsal skin of mice.
Subsequently, the size and number of the spots increased
on the irradiated area (Fig 1c, d). The spots had a diameter
of less than 2 mm and were light brown (Fig 1d).
Epidermal hyperplasia and accumulation of melanin
granules in the epidermis were noted on skin specimens
taken immediately after 5 wk UV irradiation (Fig 1i). A
number of active dendritic melanocytes were visualized by
dopa staining (Fig 1e). Melanocytes overspread in the ep-
idermis showed pigmentation, except around hair follicles.
Figure 1
Process of delayed pigmented spots formation on the dorsal skin of HR/De  HR-1 F1 mouse. Skin appearance (a–d), epidermis stained with
dopa reaction (e–h), and tissue sections stained with hematoxylin–eosin (i–p) in acute pigmentation period, depigmentation period, delayed
pigmentation period I, and delayed pigmentation period II. Delayed pigmented spots began to appear approximately 10 wk after the last irradiation.
And then they became gradually darker and larger (c and d). Active and dendritic melanocytes were seen except at hair follicles in the epidermis of
the skin prepared immediately after a 5-wk ultraviolet (UV) irradiation (e). Active and dendritic melanocytes appear only in areas showing delayed
pigmented spots in the epidermis of the skin prepared 37 wk after the completion of UV irradiation (h). The morphology of melanocytes was very
similar to that in (e). Hyperplasia was seen in a skin specimen prepared immediately after a 5-wk UV irradiation (i). Hyperplasia was also seen in a
skin specimen prepared 37 wk after the completion of UV irradiation (L) and melanin particles were stained only in the epidermis, not in the dermis, in
delayed pigmented lesions (l). Scale bars¼ 5 mm (a–d), 50 mm (e–h), and 100 mm (i–p).
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Epidermal hyperplasia was also observed in skin specimens
taken from the irradiated area 37 wk after the completion
of UV irradiation (Fig 1l). Active melanocytes similar to those
observed during the acute pigmentation period were
present only in areas showing delayed pigmented spots
(Fig 1h).
Gene expression patterns DNA microarray hybridization
was used to measure the changes in mRNA levels of 8737
mouse genes in the acute pigmentation period (12 wk), the
depigmentation period (17 wk), and the delayed pigmenta-
tion period II (52 wk). In order to eliminate the variability
because of inter-individual mouse differences, half of the
dorsal skin of each mouse was shielded with an aluminum
foil during irradiation. Total RNA was prepared from both
irradiated and non-irradiated areas of the dorsal skin of the
same mouse and reverse-transcribed in the presence of
cyanine-labeled dCTP. The Cy3/Cy5-labeled probes pre-
pared from the same mouse were applied to the same DNA
microarray. The delayed pigmentation period was examined
in quadruple and the acute pigmentation and depigmenta-
tion periods were examined in duplicate. Table I displays the
list of genes that showed more than 2-fold upregulation in
the delayed pigmentation period. The most strongly in-
duced gene was small proline-rich protein 2A, followed by
monocyte chemoattractant protein-2 (MCP-2). Twenty-one
genes showed a greater than 2-fold differential expression.
Among them, interferon (IFN)-stimulated genes, such as
MCP-2, IFN-stimulated protein 15 kDa (ISG15), and IFN-
induced GTPase, accounted for half. The upregulation of
the IFN-stimulated genes was detected in the acute pig-
mentation period and either remained at almost the same
level or increased in the later periods, whereas the expres-
sion of the other genes increased gradually from the acute
pigmentation period through to the delayed pigmentation
period (Fig 2).
Table I. Genes that showed more than 2-fold upregulation in
delayed pigmentation period II
Gene name UniGene
Delayed
pigmentation II
Small proline-rich protein 2A Mm.6853 23.25
Monocyte chemoattractant
protein-2 (MCP-2)
Mm.42029 20.73
Myocyte enhancer factor 2C Mm.24001 4.78
Interferon-stimulated protein 15
kDa (ISG15)
Mm.4950 4.07
20–50 oligoadenylate
synthetase-like
Mm.228363 4.07
Monokine induced by
interferon-g (MIG)
Mm.766 3.92
Interferon-inducible protein 10
(IP-10)
Mm.877 3.57
Keratin complex 2, basic, gene
6a
Mm.302399 3.37
Guanylate nucleotide binding
protein 2 (GBP2)
Mm.24038 3.29
Interferon g induced GTPase Mm.33902 3.20
Glutathione S-transferase, a 4 Mm.2662 2.97
Insulin-like growth factor
binding protein 6
Mm.29389 2.92
Tenascin C Mm.980 2.88
Osteoblast specific factor 2
(fasciclin I-like)
Mm.236067 2.88
Interferon-g inducible protein,
47 kDa
Mm.24769 2.84
Peptidylprolyl isomerase C-
associated protein
Mm.3152 2.62
T cell specific GTPase Mm.15793 2.58
Complement component 2
(within H-2S)
Mm.283217 2.44
Ubiquitin-specific protease 18
(USP18)
Mm.326911 2.18
Fatty acid binding protein 5,
epidermal
Mm.741 2.11
Interferon-inducible GTPase Mm.216398 2.10
Genes were sorted based on the average value of the fold change in
four analyses in the delayed pigmentation period II.
Figure2
Time course of expression of genes that showed more than 2-fold
upregulation in delayed pigmentation period II. The average values
of the fold changes in two analyses in the acute pigmentation period
and the depigmentation period and four analyses in the delayed pig-
mentation period II are plotted. (1) small proline-rich protein 2A, (2)
monocyte chemoattractant protein-2 (MCP-2), (3) myocyte enhancer
factor 2C, (4) interferon (IFN)-stimulated protein 15 kDa (ISG15), (5) 20–
50 oligoadenylate synthetase-like, (6) monokine induced by IFN-g (MIG),
(7) IFN-inducible protein 10 (IP-10), (8) keratin complex 2, basic, gene
6a, (9) guanylate nucleotide binding protein 2 (GBP2), (10) IFN-g-in-
duced GTPase, (11) tenascin, (12) osteoblast-specific factor 2. IFN-g-
stimulated genes (solid lines) and non-IFN-g–stimulated genes (dotted
lines).
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Other than IFN-stimulated genes, differentiation-related
genes such as small proline-rich protein 2A, keratin com-
plex, and tenascin were included in the list (Table I).
Validation of cDNA microarray results by RT-PCR and
immunohistochemistry To validate the expression levels
of genes from the cDNA microarray analysis, RT-PCR was
performed, with GAPDH as a control. The time-course ex-
pression profiles of MCP-2 obtained by two independent
methods were similar. The band was detected at 5 wk in the
acute pigmentation period and the increased intensity was
observed in the delayed pigmentation period (Fig 3A). As an
additional means to confirm our data at the protein level, we
performed immunohistochemical analysis of MCP-2. The
time-course protein expression profile of MCP-2 was similar
to that of mRNA expression detected by DNA microarray
and RT-PCR (Fig 3B).
Analyses of IFN-c expression by ELISA and RT-PCR To
confirm that the delayed pigmentation is associated with
expression of IFN-g, we performed ELISA assays to deter-
mine the concentration of IFN-g in delayed pigmented le-
sions. The concentration of IFN-g was approximately 4-fold
higher in delayed pigmented lesions compared with non-
irradiated controls (3.28  1.38 pg vs 0.80  0.29 pg per
100 mg protein) (Fig 4A). mRNA expression of IFN-g in de-
layed pigmented lesions was enhanced compared with
non-irradiated controls (Fig 4B).
Distribution patterns of CD8þ T lymphocytes MCP-2,
inducible protein 10 (IP-10), and monokine induced by IFN-g
(MIG) are all chemotactic for T lymphocytes. We studied the
time course of the emergence of CD8þ T lymphocytes by
immunohistochemical analyses. CD8þ T lymphocytes were
detected in the epidermis in the acute pigmentation period
and that number strikingly increased in the depigmentation
period and thereafter probably because of the infiltration of
CD8þ T lymphocytes (Fig 5).
Localization and distribution of other inﬂammatory
cells To examine the involvement of other inflammatory
cells besides T lymphocytes, Giemsa staining was per-
Figure 3
Time course analysis of the expression of monocyte chemoattractant protein-2 (MCP-2) mRNA and protein. (A) Time-course analysis of
MCP-2 mRNA expression in the process of delayed pigment spots formation was examined using RT-PCR. Lane 1, non-irradiated control; lane 2, 8
wk (ultraviolet (UV) irradiated for 1 wk); lane 3, 12 wk (UV irradiated for 5 wk); lane 4, 14 wk (UV irradiated for 7 wk); lane 5, 17 wk; lane 6, 23 wk; lane
7, 34 wk; lane 8, 52 wk. (B) Immunohistochemical detection of MCP-2 in UV-irradiated and non-irradiated skin. Tissue sections from UV-irradiated
and non-irradiated epidermis were analyzed for expression and localization of MCP-2 using anti-MCP-2 antibody. (a–d) UV irradiated, (e–h) non-
irradiated control. Scale bar¼100 mm (a–h).
Figure 4
Quantification of the concentration of interferon (IFN)-c in the ep-
idermis in delayed pigmentation period. (A) Concentration of murine
IFN-g in the epidermis of mice in delayed pigmented lesions and non-
irradiated control was determined by ELISA. Results represent the
mean  SD of four independent collections from four independent
mice. (B) mRNA expression of IFN-g in delayed pigmented lesions was
examined in triplicate using RT-PCR. C, non-irradiated control; UV, ul-
traviolet irradiated.
1056 AOKI AND MORO THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
formed. An increased number of Giemsa-positive cells was
detected in the dermis beneath the delayed pigmented le-
sions, whereas fewer or no Giemsa-positive cells were
found in non-irradiated controls (Fig 6A). Some of the
Giemsa-positive cells showed granule release (Fig 6C).
Immunohistochemical analysis with mAb to c-kit also re-
vealed the existence of c-kitþ cells gathered beneath the
delayed pigmented lesions, whereas fewer or no c-kitþ
cells were found in non-irradiated controls (Fig 6B). Taking
account of the result of Giemsa staining, these cells are
thought to be mast cells.
Western blot analysis Because IFN-g signaling involves
activation of the Janus Kinase–signal transducer and
activator of transcription (JAK-STAT) pathway, tyrosine
phosphorylation of STAT-1 was examined using cell ex-
tracts prepared from delayed pigmented lesions. Equal
amounts of protein from delayed pigmentation lesions and
non-irradiated control were analyzed by western blotting for
tyrosine phosphorylation of STAT-1 using a phospho-spe-
cific antibody. Expression of ERK2 was slightly enhanced or
almost the same in delayed pigmented lesions compared
with non-irradiated controls. In contrast, STAT-1 phos-
phorylation, as well as expression, was induced in delayed
pigmented lesions compared with non-irradiated controls
(Fig 7).
Discussion
We took advantage of a unique model of delayed pig-
mented spots and the powerful tool of massive parallel
gene expression profiling to examine the underlying mech-
anisms of acquired hyperpigmentation. The characteristics
of pigmented spot formation in this model are as follows:
(1) development of delayed pigmented spots was clearly
initiated by UV irradiation. (2) Development of delayed
pigmented spots was a very local reaction: pigmented
spots appeared only in the UV-exposed area of skin.
(3) Constitutive melanoycte activation and chronic melanin
synthesis were maintained long after UV irradiation. In the
local environment, dormant melanocytes become active
and remain active without any direct UV stimulation (Fig
1G, H). The most obvious feature of the microarray data
obtained from the delayed pigmented lesions in mouse
epidermis was the upregulation of IFN-stimulated genes
(Table I). Upregulation of these genes was further support-
ed by the differential protein expression level of IFN-g in
the irradiated area and non-irradiated control area (Fig 4).
The upregulated IFN-stimulated genes in the delayed
pigmentation period can be classified into three groups.
The first group consists of genes coding for chemokines,
including monocyte chemoattractant protein-2 (MCP-2),
MIG, and IFN-IP-10. IP-10 and MIG are members of the
CXC chemokine family (Farber, 1997). IP-10 and MIG are
chemotactic for activated T lymphocytes and NK cells
through G protein-coupled receptor CXCR3 (Farber,
1997). MCP-2 is a member of the C–C chemokine family
and binds to CCR2 (Proost et al, 1996; Gong et al, 1997).
MCP-2 is chemotactic for a wide variety of inflammatory
cells including T lymphocytes, NK cells, monocytes, ma-
crophages, and basophils (Loetscher et al, 1994; Taub
et al, 1995; Uguccioni et al, 1995; Weber et al, 1995; All-
avena et al, 1996). Upregulation of these chemokines is in
accordance with the observed increase in epidermal in-
filtration of T lymphocytes (Fig 5). Infiltration of activated T
lymphocytes has been described as a common charac-
teristic of chronic inflammatory skin disorders such as
psoriasis, allergic contact dermatitis, and atopic derma-
titis (Laberge et al, 1998; Lin et al, 2001; Yawalkar et al,
2001). It is suggested that the continuous activation of
the inflammatory cycle by the action of activated T
lymphocytes may also be involved in the development
and maintenance of delayed pigmented spots in this
model.
Figure 5
Immunohistochemical detection of CD8þ T lymphocytes. Tissue sections of ultraviolet (UV)-irradiated and non-irradiated control in each four
periods were stained with a monoclonal antibody against CD8 as described in Materials and Methods. The increase in epidermis-infiltrating CD8þ T
lymphocytes began to be detected in the depigmentation period. (a–d) UV irradiated; (e–h) light microscopic observation of UV-irradiated tissue
sections; (i–l) non-irradiated control. Scale bar¼100 mm (a–l).
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The excessive accumulation of mast cells is a charac-
teristic of mastocytosis, which is observed in a variety of
tissues, most often the skin (Longley et al, 1993; Hartmann
and Henz, 2001). Dermal infiltrates of mast cells and in-
creased epidermal melanization are common features of
cutaneous mastocytosis. These are the same features ob-
served in delayed pigmented lesions in irradiated F1 mice
(Fig 6A, B). It was reported that adult patients with mast-
ocytosis carry c-kit point mutations, which result in stem
cell factor (SCF)-independent autophosphorylation of the
receptor and autonomous cell growth (Furitsu et al, 1993;
Nagata et al, 1995). In the case of pediatric patients, local
excessive production of SCF is speculated to be the cause
of accumulation of mast cells (Kambe and Miyachi, 2002).
But, the involvement of UV irradiation in mastocytosis has
not been reported. It is possible that the excessive produc-
tion of chemokines and cytokines, including SCF, takes
place in delayed pigmented lesions. Although the up-
regulation of SCF mRNA expression was not detected, in-
creased local concentration of soluble SCF was detected
by western blotting (data not shown).
In contrast to the well-studied chemotactic mechanisms
of T lymphocytes, the mechanisms of recruitment of mast
cells remain largely unknown. SCF and anaphylatoxins (C3a
and C5a) were reported to be chemotactic for human mast
cells (Meininger et al, 1992; Hartmann et al, 1997). Recently,
high CXCR3 expression in synovial mast cells associated
with MIG and IP-10 expression in inflammatory synovial
tissues of patients with rheumatoid arthritis has been re-
ported (Ruschpler et al, 2003). MIG, IP-10, SCF, and ana-
phylatoxins may also be responsible for the mast cell
accumulation in the delayed pigmentation lesions in this
model.
The second IFN-stimulated group consists of genes
coding for proteins with GTPase activity and 2–5 oligoade-
nylate synthases. Upregulation of genes belonging to both
the 47 kDa family and the guanylate binding protein (GBP)
67-kDa family was detected. Although little is known
Figure 6
Localization and distribution of mast cells (MC). (A) Tissue sections were stained using Giemsa’s solution. (a–d) Ultraviolet (UV)-irradiated; (e–h)
non-irradiated control. The increase in dermal MC was observed in close vicinity to the delayed pigmented lesions (c, d). Scale bar¼100 mm (a–h).
(B) Immunohistochemical detection of c-kitþ cells. Tissue sections from UV-irradiated and non-irradiated skin were analyzed for expression and
localization of c-kit using an anti-c-kit antibody. (a–d) UV irradiated; (e–h) non-irradiated control. Scale bar¼ 100 mm (a–h). (C) MC degranulation was
observed in delayed pigmented lesions at a higher magnification of  400. Scale bars¼100 mm (left) and 20 mm (right).
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concerning the functions of these families, GBP have been
reported to function in the regulation of some aspects of
growth control by IFN. NIH3T3 expressing guanylate nuc-
leotide binding protein 2 (GBP2) grew at a faster rate (Go-
rbacheva et al, 2002). Epidermal hyperplasia was observed
in delayed pigmented lesions, and whether GBP2 also pro-
motes keratinocyte growth will be the subject of a future
study. The 2–5 oligoadenylate synthases are part of a reg-
ulated RNA decay pathway known as the 2–5A system (Li
et al, 2000). The 2–5A system is implicated in the mecha-
nism of the antiviral action of IFN. Moreover, the 2–5A sys-
tem has been implicated in the control of cell growth,
differentiation, and apoptosis. The relationship between in-
duction of this gene and hyperplasia will also be the subject
of a future study.
The third IFN-stimulated group consists of genes coding
for ubiquitin-related proteins, such as ISG15 and ubiquitin
specific protease 18 (USP18). ISG15 is a ubiquitin-like pro-
tein that conjugates to a variety of proteins in the presence
of IFN-g or lipopolysaccharide. It is reported that protein
ISGylation modulates the JAK-STAT signaling pathway
(D’Cunha et al, 1996; Malakhova et al, 2003). USP18 (also
known as UBP43) is a major ISG15-specific protease, and
lack of UBP43 activity results in a profound increase in the
level of protein ISGylation that is associated with enhanced
and prolonged JAK-STAT signaling (Malakhov et al, 2002). A
proper cellular balance between ISG15-conjugated proteins
and UBP43 is thought to be crucial for maintenance of cell
function. The induction of mRNA expression of ISG15 is
higher than that of USP18 in delayed pigmented lesions.
Constitutive STAT-1 tyrosine phosphorylation in delayed
pigmented lesions might be attributed to the higher induc-
tion of ISG15 (Fig 7). The constitutive JAK-STAT pathway
activation in turn may account for the hypersensitivity to
IFN-g, resulting in upregulation of a number of IFN-stimu-
lated genes in delayed pigmented lesion.
Other than IFN-stimulated genes, small proline-rich pro-
tein 2A was the most upregulated gene. Small proline-rich
protein 2A is a component of cornified envelope. The up-
regulation of small proline-rich protein 2 in UVB-irradiated
primary human keratinocytes has been previously reported
(Sesto et al, 2002). High induction is considered to be the
cause of epidermal hyperplasia observed in the UV-irradi-
ated regions (Fig 1).
In conclusion, we would like to present a hypothesis
based on the results described in this paper (Fig 8). When
skin is irradiated, IFN-g is produced in the epidermis. The
initial source of IFN-g may be residual epidermal T lymph-
ocytes (Hassan-Zahraee et al, 2002). A small but significant
and sustained production of IFN-g in epidermal skin ex-
posed to UVB irradiation was previously reported (Shen
et al, 1999). Secreted IFN-g stimulates surrounding keratin-
ocytes by binding to IFN-g receptors and activating the
JAK-STAT pathway. Transcription of IFN-g-stimulated genes
is upregulated and MCP-2, IP-10, MIG, and ISG15 are pro-
duced. ISG15 may modulate the JAK-STAT pathway in ker-
atinocytes. Secreted MCP-2, IP-10, and MIG recruit T
lymphocytes. Infiltrated T lymphocytes may produce further
chemokines and cytokines, including IFN-g. Chemokines
and cytokines secreted from T lymphocytes and keratin-
ocytes also caused infiltration and activation of mast cells,
monocytes, and macrophages. The number of CD68þ ma-
crophages tends to increase in pigmented spots lesions
(data not shown). Keratinocytes, T lymphocytes, mast cells,
and macrophages are involved in the formation of an inter-
active network, and provide a suitable local environment for
melanocyte activation. In this environment, melanocytes are
exposed to an extensive array of mediators secreted from
these cells. Reciprocal activation among these cells main-
tains the interactive network, resulting in constitutive me-
lanocyte activation and chronic melanin synthesis in
delayed pigmented lesions. IFN-g may play a pivotal role
in these interactions.
Figure 7
Tyrosine phosphorylation of STAT-1 in delayed pigmented lesions.
Cell extracts were prepared from the irradiated and non-irradiated ep-
idermis in the delayed pigmentation period II. An equal amount of pro-
tein (20 mg) was analyzed by western blotting. C, non-irradiated control;
UV, ultraviolet irradiated.
Figure8
Hypothetical mechanism of delayed pigmented spot formation.
Secretion of interferon (IFN)-g from epidermal residual T lymphocytes
initiates the whole process. Keratinocytes and recruited inflammatory
cells form a local environment in which melanoytes are exposed to an
extensive array of mediators.
MICROARRAY ANALYSIS OF DELAYED PIGMENTED SPOTS 1059124 : 5 MAY 2005
Materials and Methods
Animals F1 hairless mice of HR-1  HR/De, which have pigment-
ed eyes, ears, and tail, were used. The mice were 7 wk old at the
start of the experiments, and were given water and a commercial
diet (Oriental Yeast, CRF-1, Tokyo, Japan), ad libitum. Ambient
lighting was automatically regulated on a 12-h light/day cycle. All
animal studies were approved by the Shiseido Research Center
Subcommittee on Research Animal Care.
UV radiation The UVB light source was a bank of seven Toshiba
FL-20 SE fluorescent lamps (Toshiba Electric, Tokyo, Japan), with a
peak emission at 305 nm. The irradiance was 0.31 mW per cm2, as
measured with a UV-Radiometer (Topcon, Tokyo, Japan). The mice
were exposed to UVB three times a week for a period of 8 wk. The
daily dose was 94 mJ per cm2, which was approximately 50% of
minimal erythemal dose (0.5 MED) in humans. During irradiation,
half of the dorsal skin of each mouse was shielded with an alumi-
num foil for non-irradiated controls.
Histology The skin of mice was taken after 5 wk irradiation (acute
pigmentation period, 12 wk), at 2 wk after completion of UV irra-
diation (depigmentation period, 17 wk), at 19 wk after the com-
pletion of UV irradiation (delayed pigmentation period I, 34 wk), and
at 37 wk after the completion of UV irradiation (delayed pigmen-
tation period II, 52 wk). Pieces of skin were fixed in buffered for-
malin, sectioned, and stained by hematoxylin–eosin or Giemsa’s
method for light microscopic observation. Other pieces of skin
were subjected to immunohistochemistry or RNA isolation.
RNA isolation and labeling Dorsal skin samples (10 mm  20
mm) were obtained and the epidermis was separated from the
dermis by heating. Epidermal sheets were placed in 1 mL of Isogen
reagent (Nippon Gene, Toyama, Japan) and total RNA was isolated
as recommended by the manufacturer. Total RNA was purified us-
ing RNeasy spin columns (Qiagen, Valencia, California) following
the instructions of the manufacturer. Total RNA concentration and
purity were determined by measuring the OD260 and OD260/280,
respectively, on a NanoDrop spectrophotometer (NanoDrop Tech-
nologies, Rockland, Delaware). The quality of total RNA was as-
sessed by electrophoretic separation on an RNA Nano lab chip in a
2100 Bioanalyzer (Agilent Technologies, Palo Alto, California). Total
RNA samples with a 28S/18S band ratio greater than 1.5 were
used for microarray target labeling. Cy3- and Cy5-labeled cDNA
probes were prepared using the Fluorescent Direct Label Kit (Ag-
ilent Technologies). For each reaction, 10 mg of total RNA was
reverse-transcribed with MMLV-RT using oligo dT priming in the
presence of cyanine-labeled dCTP. The mixed Cy3- and Cy5-labe-
led cDNA were purified using the QIAquick PCR Purification Kit
(Qiagen). The purified cDNA was lyophilized in a Sakuma EC-57CS
SpeedVac System (Sakuma, Tokyo, Japan).
Microarray hybridization The Cy3/Cy5-labeled probe was com-
bined with control targets and applied to the mouse cDNA micro-
array (Agilent Technologies). The mouse cDNA microarray contains
a total of 8737 genes. The array was placed in an Agilent hybrid-
ization chamber and incubated in the water bath at 651C for 17 h.
The array was removed from the chamber and washed for 5 min at
room temperature with 0.01% SDS, 0.5  SSC solution followed
by 0.06  SSC solution for 2 min at room temperature.
Microarray scanning and data acquisition The hybridized array
was scanned with a Microarray Scanner Bundle G2565BA (Agilent
Technologies). The TIFF array image was analyzed by feature ex-
traction (Agilent Technologies) software. Elements with a flag of
gIsFeatNonUnifOL, rIsFeatNonUnifOL, gIsBGNonUnifOL, and rI-
sBGNonUnifOL were excluded from subsequent analysis.
RT-PCR Total RNA samples were isolated with the same method
as those for microarray analysis and subjected to RT reaction with
Superscript II (Invitrogen life technologies, Carlsbad, California).
The single-stranded cDNA was then amplified by PCR in a total
volume of 50 mL containing 25 pmol of each primer, 200 mM dNTP,
DNA polymerase buffer, 2.5 U of Advantage genomic polymerase
(Clontech, Palo Alto, California), and 5 ng of single-stranded DNA.
The PCR condition was 941C 2 min, 941C 15 s, 601C 30 s, 721C
1 min 30–45 cycles, and 721C 10 min. PCR products were analy-
zed by electrophoresis through 1.5% agarose gel. The primers
used in this study were MCP-2 (sense: 53-75 CCTTCAACATGAA-
GATCTACGCA, anti-sense: 371-350 AACTCAGGTGTGAAGG-
TTCAAG) and IFN-g (sense: 110-132 ATGAACGCTACACACTGC-
ATCTT, anti-sense: 580-558 GAATCAGCAGCGACTCCTTTTCC).
Analysis of IFN-c production by ELISA The frozen epidermal
sheets were pulverized using a Cryo-press (Microtec, Chiba, Ja-
pan). Pulverized samples were placed into 200 mL of phosphate-
buffered saline (PBS) with protease inhibitors. After standing on ice
for 20 min, the cell extracts were cleared by centrifugation at
12,000 r.p.m. (11,000 g) for 20 min at 41C. IFN-g content in cell
extracts containing an equal amount of total protein was assessed
using mouse-specific cytokine ELISA kits (Quantikine, R&D sys-
tems, Minneapolis, Minnesota) following the instruction of the
manufacturer. Experiments were performed in quadruple and the
data are displayed with SD values.
Immunohistochemistry Mouse skins were fixed in formalin, de-
hydrated through ethyl alcohol and xylene, and embedded in par-
affin. Alternatively, skins were prepared as frozen blocks for anti-
CD8. Serial 3–5mm sections were cut. Tissue sections were
blocked and incubated with appropriate primary antibodies over-
night at 41C, thoroughly rinsed with PBS, and overlaid with HRP-
conjugated anti-IgG for 30 min at room temperature. After three
washings, tyramid-FITC complex (TSA-plus Fluorescein System:
Perkin Elmer Life and Analytical Sciences, Boston, Massachusetts)
was added for 10 min. Slides were rinsed well with PBS, and ob-
served by fluoromicroscopy. The antibodies used in this study
were anti-MCP-2 (R&D systems 1:25), anti-CD8a (Ly-2) (Pharmin-
gen, San Diego, California, 1:200), and anti-c-kit (K963) (IBL,
Gunma, Japan, 1:20).
Western blot analysis The epidermal sheets were placed into
200 mL of lysis buffer (PBS, 1% Nonidet P-40%, 0.5% sodium
deoxycholate, 0.1% SDS, 100 mg per mL phenylmethylsulfonyl flu-
oride, 100 mg per mL aprotinin, 1 mg per mL leupeptin, and 1 mM
sodium orthovanadate). After standing on ice for 20 min, the cell
lysates were cleared by centrifugation at 12,000 r.p.m. (11,000 g)
for 20 min at 41C. Cell lysates containing an equal amount of protein
were resolved by electrophoresis on 0.1% SDS and 10% polyacryl-
amide gels. The proteins were transferred electrophoretically to an
Immobilon-P nitrocellulose membrane (Millipore, Bedford, Massa-
chusetts). After blocking in 10 mM Tris-HCl (pH 8.0) containing 150
mM sodium chloride, 0.1% Tween 20, and 5% (w/v) nonfat dry milk,
the membrane was treated with appropriate primary antibodies,
followed by incubation with horseradish peroxidase-conjugated
secondary antibodies. The antigen–antibody complexes were
detected using the ECL chemiluminescence reagent kit (Amersham
Biosciences, Little Chalfont, UK). The antibodies used in this study
were anti-STAT-1 (Cell Signalling Technology, Beverly, Massachu-
setts, 1:1000), anti-phospho-STAT-1 (Cell Signalling Technology,
1:1000), anti-ERK2 (New England BioLabs, Beverly, Massachusetts,
1:1000), and anti-phospho-ERK2 (New England BioLabs, 1:1000).
DOI: 10.1111/j.0022-202X.2005.23721.x
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